BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

SecurityBCRX / BioCryst Pharmaceuticals, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in BCRX / BioCryst Pharmaceuticals, Inc.

On November 14, 2024 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of BioCryst Pharmaceuticals, Inc. (US:BCRX) valued at $0 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 10,609 shares of BioCryst Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (BCRX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BCRX / BioCryst Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-11-14 2024-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -10,609 -100.00 0 -100.00
2024-08-14 2024-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 10,609 10,609 66 0.0001
2024-05-15 2024-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -16,364 -100.00 0 -100.00
2024-02-14 2023-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 16,364 16,364 98 0.0001
2023-08-23 2023-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -15,825 -100.00 0 0.0000
2023-05-15 2023-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 15,825 15,825 0 0.0002
2022-08-15 2022-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -27,389 -100.00 0 -100.00
2022-05-16 2022-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 27,389 27,389 450 0.0006
2022-02-14 2021-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -32,855 -100.00 0 -100.00
2021-11-12 2021-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 32,855 -33,945 -50.82 472 -54.40 0.0005
2021-08-06 2021-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 66,800 -29,102 -30.35 1,035 8.04 0.0016
2021-05-14 2021-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 95,902 33,022 52.52 958 102.97 0.0014
2021-02-12 2020-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 62,880 26,238 71.61 472 234.75 0.0007
2020-11-13 2020-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 36,642 -1,373 -3.61 141 -25.40 0.0003
2020-08-13 2020-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 38,015 512 1.37 189 152.00 0.0005
2020-05-11 2020-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 37,503 19,552 108.92 75 29.31 0.0002
2020-02-12 2019-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 17,951 17,951 58 0.0001
2019-11-14 2019-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -47,732 -100.00 0 -100.00
2019-08-20 2019-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 47,732 47,732 181 0.0005
2019-05-15 2019-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -27,701 -100.00 0 -100.00
2019-02-13 2018-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 27,701 17,075 160.69 218 169.14 0.0006
2018-11-14 2018-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 10,626 10,626 81 0.0002
2018-02-14 2017-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -10,480 -100.00 0 -100.00
2017-11-15 2017-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 10,480 10,480 55 0.0002
2017-08-14 2017-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -33,605 -100.00 0 -100.00
2017-05-15 2017-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 33,605 -33,020 -49.56 280 -5.41 0.0015
2016-11-14 2016-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 66,625 66,625 296 0.0014
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-18 2025-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 45,500 5.08 426 25.00 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 43,300 -20.26 340 -16.67 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 54,300 33.74 409 32.04 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 40,600 -12.31 309 8.04 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 46,300 91.32 286 134.43 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 24,200 -89.95 123 -91.54 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 240,800 46.21 1,442 23.67 n/a n/a n/a
2023-11-15 2023-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 164,700 83.00 1,166 86.26 n/a n/a n/a
2023-08-23 2023-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 90,000 -12.37 626 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 102,700 1 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 205,600 32.90 2,541 51.97 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 154,700 -18.96 1,672 -46.72 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 190,900 3,138 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 239,900 59.72 3,450 48.26 n/a n/a n/a
2021-08-06 2021-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 150,200 146.63 2,327 282.73 n/a n/a n/a
2021-05-14 2021-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 60,900 -10.31 608 19.45 n/a n/a n/a
2021-02-12 2020-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 67,900 261.17 509 606.94 n/a n/a n/a
2020-11-13 2020-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 18,800 -56.38 72 -66.51 n/a n/a n/a
2020-08-13 2020-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 43,100 -28.17 215 80.67 n/a n/a n/a
2020-05-11 2020-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 60,000 33.33 119 -17.93 n/a n/a n/a
2020-02-12 2019-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 45,000 62.45 145 64.77 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 27,700 23.11 88 3.53 n/a n/a n/a
2019-08-20 2019-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 22,500 85 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 18,700 -31.50 147 -29.33 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 27,300 208 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 45,200 237 n/a n/a n/a
2017-08-14 2017-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 46,200 -37.23 384 17.07 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 73,600 328 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-18 2025-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 14,300 -32.86 134 -20.36 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 21,300 13.90 167 19.29 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 18,700 -37.87 141 -38.86 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 30,100 0.33 229 23.78 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 30,000 170.27 185 230.36 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 11,100 -49.32 56 -57.25 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 21,900 82.50 131 55.95 n/a n/a n/a
2023-11-15 2023-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 12,000 -25.00 85 -24.32 n/a n/a n/a
2023-08-23 2023-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 16,000 -36.25 111 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 25,100 0 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 56,200 2.00 695 16.61 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 55,100 -26.14 596 -51.39 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 74,600 1,226 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 96,600 -18.89 1,389 -24.72 n/a n/a n/a
2021-08-06 2021-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 119,100 80.18 1,845 179.55 n/a n/a n/a
2021-05-14 2021-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 66,100 11.84 660 48.98 n/a n/a n/a
2021-02-12 2020-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 59,100 24.42 443 143.41 n/a n/a n/a
2020-11-13 2020-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 47,500 50.32 182 15.92 n/a n/a n/a
2020-08-13 2020-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 31,600 4.29 157 161.67 n/a n/a n/a
2020-05-11 2020-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 30,300 -8.46 60 -43.93 n/a n/a n/a
2020-02-12 2019-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 33,100 107 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-20 2019-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 76,300 289 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 23,600 29.67 186 33.81 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 18,200 139 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 64,500 338 n/a n/a n/a
2017-08-14 2017-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 52,800 -58.46 439 -22.44 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 127,100 566 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.